Human Papillomavirus Vaccines Current Status and Future Prospects

Grants

Funding Acknowledgements

We would like to acknowledge Ms Yuli Chang (University of North Carolina, Gillings School of Global Public Health) for her assistance in the preparation of this manuscript. No sources of funding were used to assist in the preparation of this review. SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline (GSK), and lecture and consultancy fees from Merck and Co. SMG reports having previously owned stock in Commonwealth Serum Laboratories. SMG has received grant support through her institution from Merck and Co. and GSK to perform clinical trials for HPV/cervical cancer vaccines. SMG also reports being a member of the Merck Global Advisory Board and Scientific Advisory Committee. JSS has received advisory board fees from GSK, and grant support from GSK and Merck and Co.